Showing 291-300 of 5621 results for "".
Virtual Reality: Coming to a Lane Near You
https://modernod.com/topics/glaucoma/virtual-reality-coming-to-a-lane-near-you/38017/VR and its cousin, augmented reality, offer great potential in the realm of eye care.Scleral Lenses as Therapeutic Devices
https://modernod.com/topics/contact-lenses/scleral-lenses-as-therapeutic-devices/37978/The potential of these contact lenses to treat some ocular surface disease shouldn’t be overlooked.Boost Your Glaucoma Drug Knowledge
https://modernod.com/topics/glaucoma/boost-your-glaucoma-drug-knowledge/37906/It’s helpful to know the treatment options available.What’s Your Innovation?
https://modernod.com/mod-issues/2022-mar/whats-your-innovation/38386/An Attempt to Provide Veterans With Greater Access to Care
https://modernod.com/articles/significant-findings/an-attempt-to-provide-veterans-with-greater-access-to-care/37753/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatAre You Side Effect Savvy?
https://modernod.com/mod-issues/2023-mar/are-you-side-effect-savvy/39129/A review of common adverse reactions related to intravitreal injections and some guidance on the optometrist’s role in identifying and managing these complications.Current and Future Glaucoma Management: An Update on Existing Options and the Therapeutic Pipeline
https://modernod.com/topics/glaucoma/current-and-future-glaucoma-management-an-update-on-existing-options-and-the-therapeutic-pipeline/37954/Alcon Gains FDA Approval for Novel DED Drug
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-gains-fda-approval-for-novel-ded-drug/37087/Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials. Learn more abA Place for House Calls in Optometry
https://modernod.com/topics/patient-care/a-place-for-house-calls-in-optometry/38789/Consider delivering eye care where it’s needed most.Keeping Eye Care Where It Belongs
https://modernod.com/topics/health-policy/keeping-eye-care-where-it-belongs/39836/Helpful steps to steer patients away from ERs and urgent care centers and into OD practices.